id	sid	tid	token	lemma	pos
cord-291585-a6y8k1a5	1	1	key	key	JJ
cord-291585-a6y8k1a5	1	2	:	:	:
cord-291585-a6y8k1a5	1	3	cord-291585-a6y8k1a5	cord-291585-a6y8k1a5	NNP
cord-291585-a6y8k1a5	1	4	authors	author	NNS
cord-291585-a6y8k1a5	1	5	:	:	:
cord-291585-a6y8k1a5	1	6	Kow	Kow	NNP
cord-291585-a6y8k1a5	1	7	,	,	,
cord-291585-a6y8k1a5	1	8	Chia	Chia	NNP
cord-291585-a6y8k1a5	1	9	Siang	Siang	NNP
cord-291585-a6y8k1a5	1	10	;	;	:
cord-291585-a6y8k1a5	1	11	Hasan	Hasan	NNP
cord-291585-a6y8k1a5	1	12	,	,	,
cord-291585-a6y8k1a5	1	13	Syed	Syed	NNP
cord-291585-a6y8k1a5	1	14	Shahzad	Shahzad	NNP
cord-291585-a6y8k1a5	2	1	title	title	NN
cord-291585-a6y8k1a5	2	2	:	:	:
cord-291585-a6y8k1a5	3	1	The	the	DT
cord-291585-a6y8k1a5	3	2	use	use	NN
cord-291585-a6y8k1a5	3	3	of	of	IN
cord-291585-a6y8k1a5	3	4	antiplatelet	antiplatelet	JJ
cord-291585-a6y8k1a5	3	5	agents	agent	NNS
cord-291585-a6y8k1a5	3	6	for	for	IN
cord-291585-a6y8k1a5	3	7	arterial	arterial	JJ
cord-291585-a6y8k1a5	3	8	thromboprophylaxis	thromboprophylaxis	NN
cord-291585-a6y8k1a5	3	9	in	in	IN
cord-291585-a6y8k1a5	3	10	COVID-19	COVID-19	NNP
cord-291585-a6y8k1a5	3	11	date	date	NN
cord-291585-a6y8k1a5	3	12	:	:	:
cord-291585-a6y8k1a5	3	13	2020	2020	CD
cord-291585-a6y8k1a5	3	14	-	-	HYPH
cord-291585-a6y8k1a5	3	15	08	08	CD
cord-291585-a6y8k1a5	3	16	-	-	HYPH
cord-291585-a6y8k1a5	3	17	28	28	CD
cord-291585-a6y8k1a5	3	18	journal	journal	NN
cord-291585-a6y8k1a5	3	19	:	:	:
cord-291585-a6y8k1a5	3	20	Rev	Rev	NNP
cord-291585-a6y8k1a5	3	21	Esp	Esp	NNP
cord-291585-a6y8k1a5	3	22	Cardiol	Cardiol	NNP
cord-291585-a6y8k1a5	3	23	(	(	-LRB-
cord-291585-a6y8k1a5	3	24	Engl	Engl	NNP
cord-291585-a6y8k1a5	3	25	Ed	Ed	NNP
cord-291585-a6y8k1a5	3	26	)	)	-RRB-
cord-291585-a6y8k1a5	3	27	DOI	DOI	NNP
cord-291585-a6y8k1a5	3	28	:	:	:
cord-291585-a6y8k1a5	3	29	10.1016/	10.1016/	CD
cord-291585-a6y8k1a5	4	1	j.rec.2020.08.009	j.rec.2020.08.009	NNP
cord-291585-a6y8k1a5	4	2	sha	sha	NNP
cord-291585-a6y8k1a5	4	3	:	:	:
cord-291585-a6y8k1a5	5	1	7d458351b444e08f5e5f94508b05178f2544fed4	7d458351b444e08f5e5f94508b05178f2544fed4	CD
cord-291585-a6y8k1a5	5	2	doc_id	doc_id	CD
cord-291585-a6y8k1a5	5	3	:	:	:
cord-291585-a6y8k1a5	5	4	291585	291585	CD
cord-291585-a6y8k1a5	5	5	cord_uid	cord_uid	NNS
cord-291585-a6y8k1a5	5	6	:	:	:
cord-291585-a6y8k1a5	5	7	a6y8k1a5	a6y8k1a5	NN
cord-291585-a6y8k1a5	6	1	nan	nan	NNP
cord-291585-a6y8k1a5	7	1	No	no	DT
cord-291585-a6y8k1a5	7	2	funding	funding	NN
cord-291585-a6y8k1a5	7	3	was	be	VBD
cord-291585-a6y8k1a5	7	4	received	receive	VBN
cord-291585-a6y8k1a5	7	5	for	for	IN
cord-291585-a6y8k1a5	7	6	the	the	DT
cord-291585-a6y8k1a5	7	7	writing	writing	NN
cord-291585-a6y8k1a5	7	8	of	of	IN
cord-291585-a6y8k1a5	7	9	this	this	DT
cord-291585-a6y8k1a5	7	10	manuscript	manuscript	NN
cord-291585-a6y8k1a5	7	11	.	.	.
cord-291585-a6y8k1a5	8	1	El	El	NNP
cord-291585-a6y8k1a5	8	2	uso	uso	NNP
cord-291585-a6y8k1a5	8	3	de	de	NNP
cord-291585-a6y8k1a5	8	4	agentes	agentes	NNP
cord-291585-a6y8k1a5	8	5	antiplaquetarios	antiplaquetarios	NNP
cord-291585-a6y8k1a5	8	6	para	para	NNP
cord-291585-a6y8k1a5	8	7	la	la	NNP
cord-291585-a6y8k1a5	8	8	tromboprofilaxis	tromboprofilaxis	NNP
cord-291585-a6y8k1a5	8	9	arterial	arterial	JJ
cord-291585-a6y8k1a5	8	10	en	en	FW
cord-291585-a6y8k1a5	8	11	la	la	NN
cord-291585-a6y8k1a5	9	1	COVID-19	covid-19	VB
cord-291585-a6y8k1a5	10	1	To	to	IN
cord-291585-a6y8k1a5	10	2	the	the	DT
cord-291585-a6y8k1a5	10	3	Editor	Editor	NNP
cord-291585-a6y8k1a5	10	4	,	,	,
cord-291585-a6y8k1a5	10	5	We	-PRON-	PRP
cord-291585-a6y8k1a5	10	6	read	read	VBP
cord-291585-a6y8k1a5	10	7	with	with	IN
cord-291585-a6y8k1a5	10	8	interest	interest	NN
cord-291585-a6y8k1a5	10	9	the	the	DT
cord-291585-a6y8k1a5	10	10	retrospective	retrospective	JJ
cord-291585-a6y8k1a5	10	11	study	study	NN
cord-291585-a6y8k1a5	10	12	reported	report	VBN
cord-291585-a6y8k1a5	10	13	by	by	IN
cord-291585-a6y8k1a5	10	14	Rey	Rey	NNP
cord-291585-a6y8k1a5	10	15	et	et	NNP
cord-291585-a6y8k1a5	10	16	al	al	NNP
cord-291585-a6y8k1a5	10	17	.	.	.
cord-291585-a6y8k1a5	11	1	1	1	CD
cord-291585-a6y8k1a5	11	2	to	to	TO
cord-291585-a6y8k1a5	11	3	describe	describe	VB
cord-291585-a6y8k1a5	11	4	the	the	DT
cord-291585-a6y8k1a5	11	5	clinical	clinical	JJ
cord-291585-a6y8k1a5	11	6	characteristics	characteristic	NNS
cord-291585-a6y8k1a5	11	7	and	and	CC
cord-291585-a6y8k1a5	11	8	outcomes	outcome	NNS
cord-291585-a6y8k1a5	11	9	of	of	IN
cord-291585-a6y8k1a5	11	10	patients	patient	NNS
cord-291585-a6y8k1a5	11	11	with	with	IN
cord-291585-a6y8k1a5	11	12	novel	novel	JJ
cord-291585-a6y8k1a5	11	13	coronavirus	coronavirus	NN
cord-291585-a6y8k1a5	11	14	disease	disease	NN
cord-291585-a6y8k1a5	11	15	2019	2019	CD
cord-291585-a6y8k1a5	11	16	(	(	-LRB-
cord-291585-a6y8k1a5	11	17	COVID-19	COVID-19	NNP
cord-291585-a6y8k1a5	11	18	)	)	-RRB-
cord-291585-a6y8k1a5	11	19	who	who	WP
cord-291585-a6y8k1a5	11	20	developed	develop	VBD
cord-291585-a6y8k1a5	11	21	acute	acute	JJ
cord-291585-a6y8k1a5	11	22	arterial	arterial	JJ
cord-291585-a6y8k1a5	11	23	thrombosis	thrombosis	NN
cord-291585-a6y8k1a5	11	24	.	.	.
cord-291585-a6y8k1a5	12	1	Despite	despite	IN
cord-291585-a6y8k1a5	12	2	being	be	VBG
cord-291585-a6y8k1a5	12	3	a	a	DT
cord-291585-a6y8k1a5	12	4	small	small	JJ
cord-291585-a6y8k1a5	12	5	-	-	HYPH
cord-291585-a6y8k1a5	12	6	scale	scale	NN
cord-291585-a6y8k1a5	12	7	study	study	NN
cord-291585-a6y8k1a5	12	8	(	(	-LRB-
cord-291585-a6y8k1a5	12	9	n	n	NN
cord-291585-a6y8k1a5	12	10	=	=	SYM
cord-291585-a6y8k1a5	12	11	87	87	CD
cord-291585-a6y8k1a5	12	12	)	)	-RRB-
cord-291585-a6y8k1a5	12	13	,	,	,
cord-291585-a6y8k1a5	12	14	there	there	EX
cord-291585-a6y8k1a5	12	15	are	be	VBP
cord-291585-a6y8k1a5	12	16	a	a	DT
cord-291585-a6y8k1a5	12	17	few	few	JJ
cord-291585-a6y8k1a5	12	18	clinical	clinical	JJ
cord-291585-a6y8k1a5	12	19	trends	trend	NNS
cord-291585-a6y8k1a5	12	20	to	to	TO
cord-291585-a6y8k1a5	12	21	be	be	VB
cord-291585-a6y8k1a5	12	22	noted	note	VBN
cord-291585-a6y8k1a5	12	23	.	.	.
cord-291585-a6y8k1a5	13	1	Based	base	VBN
cord-291585-a6y8k1a5	13	2	on	on	IN
cord-291585-a6y8k1a5	13	3	the	the	DT
cord-291585-a6y8k1a5	13	4	reported	report	VBN
cord-291585-a6y8k1a5	13	5	findings	finding	NNS
cord-291585-a6y8k1a5	13	6	,	,	,
cord-291585-a6y8k1a5	13	7	we	-PRON-	PRP
cord-291585-a6y8k1a5	13	8	observed	observe	VBD
cord-291585-a6y8k1a5	13	9	that	that	IN
cord-291585-a6y8k1a5	13	10	the	the	DT
cord-291585-a6y8k1a5	13	11	proportion	proportion	NN
cord-291585-a6y8k1a5	13	12	of	of	IN
cord-291585-a6y8k1a5	13	13	COVID-19	covid-19	JJ
cord-291585-a6y8k1a5	13	14	patients	patient	NNS
cord-291585-a6y8k1a5	13	15	with	with	IN
cord-291585-a6y8k1a5	13	16	major	major	JJ
cord-291585-a6y8k1a5	13	17	cardiovascular	cardiovascular	JJ
cord-291585-a6y8k1a5	13	18	risk	risk	NN
cord-291585-a6y8k1a5	13	19	factors	factor	NNS
cord-291585-a6y8k1a5	13	20	who	who	WP
cord-291585-a6y8k1a5	13	21	developed	develop	VBD
cord-291585-a6y8k1a5	13	22	acute	acute	JJ
cord-291585-a6y8k1a5	13	23	arterial	arterial	JJ
cord-291585-a6y8k1a5	13	24	thrombosis	thrombosis	NN
cord-291585-a6y8k1a5	13	25	is	be	VBZ
cord-291585-a6y8k1a5	13	26	higher	high	JJR
cord-291585-a6y8k1a5	13	27	than	than	IN
cord-291585-a6y8k1a5	13	28	that	that	DT
cord-291585-a6y8k1a5	13	29	of	of	IN
cord-291585-a6y8k1a5	13	30	their	-PRON-	PRP$
cord-291585-a6y8k1a5	13	31	non	non	JJ
cord-291585-a6y8k1a5	13	32	-	-	JJ
cord-291585-a6y8k1a5	13	33	COVID-19	covid-19	JJ
cord-291585-a6y8k1a5	13	34	counterparts	counterpart	NNS
cord-291585-a6y8k1a5	13	35	.	.	.
cord-291585-a6y8k1a5	14	1	This	this	DT
cord-291585-a6y8k1a5	14	2	finding	finding	NN
cord-291585-a6y8k1a5	14	3	hinted	hint	VBD
cord-291585-a6y8k1a5	14	4	at	at	IN
cord-291585-a6y8k1a5	14	5	the	the	DT
cord-291585-a6y8k1a5	14	6	possibility	possibility	NN
cord-291585-a6y8k1a5	14	7	that	that	IN
cord-291585-a6y8k1a5	14	8	thromboinflammation	thromboinflammation	NN
cord-291585-a6y8k1a5	14	9	plays	play	VBZ
cord-291585-a6y8k1a5	14	10	a	a	DT
cord-291585-a6y8k1a5	14	11	greater	great	JJR
cord-291585-a6y8k1a5	14	12	role	role	NN
cord-291585-a6y8k1a5	14	13	for	for	IN
cord-291585-a6y8k1a5	14	14	the	the	DT
cord-291585-a6y8k1a5	14	15	development	development	NN
cord-291585-a6y8k1a5	14	16	of	of	IN
cord-291585-a6y8k1a5	14	17	arterial	arterial	JJ
cord-291585-a6y8k1a5	14	18	thrombosis	thrombosis	NN
cord-291585-a6y8k1a5	14	19	in	in	IN
cord-291585-a6y8k1a5	14	20	COVID-19	covid-19	JJ
cord-291585-a6y8k1a5	14	21	patients	patient	NNS
cord-291585-a6y8k1a5	14	22	than	than	IN
cord-291585-a6y8k1a5	14	23	traditional	traditional	JJ
cord-291585-a6y8k1a5	14	24	cardiovascular	cardiovascular	JJ
cord-291585-a6y8k1a5	14	25	risk	risk	NN
cord-291585-a6y8k1a5	14	26	factors	factor	NNS
cord-291585-a6y8k1a5	14	27	.	.	.
cord-291585-a6y8k1a5	15	1	In	in	IN
cord-291585-a6y8k1a5	15	2	addition	addition	NN
cord-291585-a6y8k1a5	15	3	,	,	,
cord-291585-a6y8k1a5	15	4	the	the	DT
cord-291585-a6y8k1a5	15	5	mortality	mortality	NN
cord-291585-a6y8k1a5	15	6	rate	rate	NN
cord-291585-a6y8k1a5	15	7	of	of	IN
cord-291585-a6y8k1a5	15	8	COVID-19	covid-19	JJ
cord-291585-a6y8k1a5	15	9	patients	patient	NNS
cord-291585-a6y8k1a5	15	10	with	with	IN
cord-291585-a6y8k1a5	15	11	arterial	arterial	JJ
cord-291585-a6y8k1a5	15	12	thrombosis	thrombosis	NN
cord-291585-a6y8k1a5	15	13	was	be	VBD
cord-291585-a6y8k1a5	15	14	high	high	JJ
cord-291585-a6y8k1a5	15	15	(	(	-LRB-
cord-291585-a6y8k1a5	15	16	44.7	44.7	CD
cord-291585-a6y8k1a5	15	17	%	%	NN
cord-291585-a6y8k1a5	15	18	)	)	-RRB-
cord-291585-a6y8k1a5	15	19	,	,	,
cord-291585-a6y8k1a5	15	20	which	which	WDT
cord-291585-a6y8k1a5	15	21	indicates	indicate	VBZ
cord-291585-a6y8k1a5	15	22	a	a	DT
cord-291585-a6y8k1a5	15	23	worse	bad	JJR
cord-291585-a6y8k1a5	15	24	prognosis	prognosis	NN
cord-291585-a6y8k1a5	15	25	with	with	IN
cord-291585-a6y8k1a5	15	26	COVID-19	covid-19	JJ
cord-291585-a6y8k1a5	15	27	patients	patient	NNS
cord-291585-a6y8k1a5	15	28	.	.	.
cord-291585-a6y8k1a5	16	1	Therefore	therefore	RB
cord-291585-a6y8k1a5	16	2	,	,	,
cord-291585-a6y8k1a5	16	3	we	-PRON-	PRP
cord-291585-a6y8k1a5	16	4	would	would	MD
cord-291585-a6y8k1a5	16	5	like	like	VB
cord-291585-a6y8k1a5	16	6	to	to	TO
cord-291585-a6y8k1a5	16	7	propose	propose	VB
cord-291585-a6y8k1a5	16	8	routine	routine	JJ
cord-291585-a6y8k1a5	16	9	antiplatelet	antiplatelet	NN
cord-291585-a6y8k1a5	16	10	therapy	therapy	NN
cord-291585-a6y8k1a5	16	11	(	(	-LRB-
cord-291585-a6y8k1a5	16	12	low	low	JJ
cord-291585-a6y8k1a5	16	13	-	-	HYPH
cord-291585-a6y8k1a5	16	14	dose	dose	NN
cord-291585-a6y8k1a5	16	15	aspirin	aspirin	NN
cord-291585-a6y8k1a5	16	16	,	,	,
cord-291585-a6y8k1a5	16	17	clopidogrel	clopidogrel	NN
cord-291585-a6y8k1a5	16	18	,	,	,
cord-291585-a6y8k1a5	16	19	ticagrelor	ticagrelor	NNP
cord-291585-a6y8k1a5	16	20	,	,	,
cord-291585-a6y8k1a5	16	21	prasugrel	prasugrel	NNP
cord-291585-a6y8k1a5	16	22	,	,	,
cord-291585-a6y8k1a5	16	23	ticlopidine	ticlopidine	NN
cord-291585-a6y8k1a5	16	24	,	,	,
cord-291585-a6y8k1a5	16	25	and	and	CC
cord-291585-a6y8k1a5	16	26	dipyridamole	dipyridamole	NN
cord-291585-a6y8k1a5	16	27	)	)	-RRB-
cord-291585-a6y8k1a5	16	28	for	for	IN
cord-291585-a6y8k1a5	16	29	arterial	arterial	JJ
cord-291585-a6y8k1a5	16	30	thromboprophylaxis	thromboprophylaxis	NN
cord-291585-a6y8k1a5	16	31	in	in	IN
cord-291585-a6y8k1a5	16	32	COVID-19	covid-19	JJ
cord-291585-a6y8k1a5	16	33	patients	patient	NNS
cord-291585-a6y8k1a5	16	34	who	who	WP
cord-291585-a6y8k1a5	16	35	are	be	VBP
cord-291585-a6y8k1a5	16	36	deemed	deem	VBN
cord-291585-a6y8k1a5	16	37	at	at	IN
cord-291585-a6y8k1a5	16	38	heightened	heightened	JJ
cord-291585-a6y8k1a5	16	39	risk	risk	NN
cord-291585-a6y8k1a5	16	40	for	for	IN
cord-291585-a6y8k1a5	16	41	the	the	DT
cord-291585-a6y8k1a5	16	42	development	development	NN
cord-291585-a6y8k1a5	16	43	of	of	IN
cord-291585-a6y8k1a5	16	44	acute	acute	JJ
cord-291585-a6y8k1a5	16	45	arterial	arterial	JJ
cord-291585-a6y8k1a5	16	46	thrombosis	thrombosis	NN
cord-291585-a6y8k1a5	16	47	.	.	.
cord-291585-a6y8k1a5	16	48	 	 	_SP
cord-291585-a6y8k1a5	17	1	Arterial	arterial	JJ
cord-291585-a6y8k1a5	17	2	thrombotic	thrombotic	JJ
cord-291585-a6y8k1a5	17	3	complications	complication	NNS
cord-291585-a6y8k1a5	17	4	in	in	IN
cord-291585-a6y8k1a5	17	5	hospitalized	hospitalize	VBN
cord-291585-a6y8k1a5	17	6	patients	patient	NNS
cord-291585-a6y8k1a5	17	7	with	with	IN
cord-291585-a6y8k1a5	17	8	COVID-19	COVID-19	NNP
cord-291585-a6y8k1a5	17	9	Lysine	Lysine	NNP
cord-291585-a6y8k1a5	17	10	acetylsalicylate	acetylsalicylate	NN
cord-291585-a6y8k1a5	17	11	+	+	CC
cord-291585-a6y8k1a5	17	12	glycine	glycine	NN
cord-291585-a6y8k1a5	17	13	impairs	impair	VBZ
cord-291585-a6y8k1a5	17	14	coronavirus	coronavirus	NN
cord-291585-a6y8k1a5	17	15	replication	replication	NN
cord-291585-a6y8k1a5	17	16	Potential	potential	JJ
cord-291585-a6y8k1a5	17	17	therapeutic	therapeutic	JJ
cord-291585-a6y8k1a5	17	18	effects	effect	NNS
cord-291585-a6y8k1a5	17	19	of	of	IN
cord-291585-a6y8k1a5	17	20	dipyridamole	dipyridamole	NN
cord-291585-a6y8k1a5	17	21	in	in	IN
cord-291585-a6y8k1a5	17	22	the	the	DT
cord-291585-a6y8k1a5	17	23	severely	severely	RB
cord-291585-a6y8k1a5	17	24	ill	ill	JJ
cord-291585-a6y8k1a5	17	25	patients	patient	NNS
cord-291585-a6y8k1a5	17	26	with	with	IN
cord-291585-a6y8k1a5	17	27	COVID-19	COVID-19	NNP
cord-291585-a6y8k1a5	17	28	The	the	DT
cord-291585-a6y8k1a5	17	29	procoagulant	procoagulant	JJ
cord-291585-a6y8k1a5	17	30	pattern	pattern	NN
cord-291585-a6y8k1a5	17	31	of	of	IN
cord-291585-a6y8k1a5	17	32	patients	patient	NNS
cord-291585-a6y8k1a5	17	33	with	with	IN
cord-291585-a6y8k1a5	17	34	COVID-19	covid-19	JJ
cord-291585-a6y8k1a5	17	35	acute	acute	JJ
cord-291585-a6y8k1a5	17	36	respiratory	respiratory	JJ
cord-291585-a6y8k1a5	17	37	distress	distress	NN
cord-291585-a6y8k1a5	17	38	syndrome	syndrome	NN